Jun 11 |
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
|
May 6 |
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
|
Apr 30 |
Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
|
Apr 26 |
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|
Apr 25 |
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Apr 25 |
POET, PCSA and BRFH are among premarket gainers
|
Apr 11 |
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
|
Apr 7 |
Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k
|
Mar 28 |
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
|
Mar 25 |
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
|